Rate My Professor Spencer Gibson

Gibson's research examines cell survival and death signaling pathways, particularly in the lymphatic system and leukemias. With over 140 peer-reviewed publications on cell death responses to stress and therapies, he has secured more than $20 million in funding. At the University of Alberta, his program investigates stress responses in lymphatic cells and their microenvironment causing dysfunction and death, using human cells, animal models, and lymphedema patient samples. Key areas include oxidative stress, lipid toxicity in cancer-related lymphedema progression, and radiation-induced cellular senescence blocking lymphatic repair. He also studies chronic lymphocytic leukemia mechanisms in lymph node microenvironments and drug resistance to targeted therapies, developing strategies to overcome resistance. Gibson leads networks such as the Alberta Lymphedema Network, collaborations with the University of Calgary, Salutaris, and others, plus a CLL Prairie Consortium between Alberta and Manitoba, spanning basic, clinical, and population sciences to advance translational research and patient outcomes.